Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

A Study on the Effects of Breathing Exercises and Aerobic Exercise on the Health of Men in Drug Rehabilitation

11 mai 2026 mis à jour par: Yongting Li, Southwest Medical University

A Study on the Effects of 8 Weeks of Resistance and Respiratory Training Combined With Aerobic Exercise on Physical Health and Quality of Life in Male Drug Rehabilitation Patients

This study aims to investigate the effects of an 8-week combined exercise program on male individuals in drug rehabilitation. The program integrates resistance-based breathing training with aerobic exercise. The investigators seek to determine whether this combined exercise program is more effective than a single form of exercise in improving participants' physical health and quality of life. The primary research questions to be addressed include: Does this combined exercise program produce better results than single-form training (resistance-based breathing training or aerobic exercise performed separately) in improving physiological indicators such as cardiopulmonary function and muscle strength in male individuals in drug rehabilitation? Does this combined exercise program yield greater benefits than single-form training in reducing anxiety and depression and improving quality of life among men in drug rehabilitation? This study will conduct a randomized controlled trial. Researchers will compare three different intervention groups-the combined training group, the resistance-breathing training group, and the aerobic exercise group-to verify the potential advantages of the combined program over single-form exercise. Participants will: Complete an 8-week exercise intervention, consisting of three sessions per week, each lasting approximately 40 minutes, under professional guidance and supervision. Undergo comprehensive assessments before and after the intervention, including cardiopulmonary function tests, body composition analysis, and questionnaires on mental health and quality of life.

Aperçu de l'étude

Statut

Recrutement

Les conditions

Intervention / Traitement

Description détaillée

  1. Exploration and Standardization of a Combined Exercise Program Tailored for Drug Rehabilitation Facilities. This section forms the foundation of the study and aims to develop an 8-week combined exercise program that is safe, effective, and easy to implement, specifically tailored to the environment and characteristics of residents in compulsory isolation drug rehabilitation centers. The content not only covers specific methods for integrating resistance-based breathing exercises with aerobic exercises (such as sequence, frequency, intensity, and duration) but also focuses on designing standardized operating procedures. These include concise instructions for participants, demonstration videos, key safety monitoring points (such as using the Borg Subjective Fatigue Scale or heart rate monitoring), and contingency plans for addressing common issues. The goal is to produce a "ready-to-use" guidebook that lays a solid foundation for subsequent implementation.
  2. Empirical Validation and Comparison of the Combined Exercise Program's Efficacy. This section constitutes the core of the study, aiming to empirically validate the actual effectiveness of this combined program for male individuals in the drug rehabilitation phase through a randomized controlled trial. Effectiveness evaluation will be entirely centered on the application objectives. It will primarily include: ① Physical Health: Focusing on verifying its effectiveness in improving areas of weakness among drug rehabilitation participants, such as cardiopulmonary function, muscle strength, and body composition; ② Mental Health and Quality of Life: Focusing on its positive impact on core rehabilitation goals such as anxiety and depression, sleep quality, and drug craving. The investigators will employ a controlled design with a combined-training group and a single-training group to address a key practical question: Does this combined program produce a "1+1>2" synergistic effect compared with single-modality resistance-breathing training or aerobic exercise, thereby offering greater practical value?

Type d'étude

Interventionnel

Inscription (Estimé)

90

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

  • Chine
      • Luzhou, Chine, 646000
        • Recrutement
        • Yongtingli
        • Contact:

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte

Accepte les volontaires sains

Oui

La description

Inclusion Criteria:

  • Male, aged 18 to 50 years, able to understand and comply with the study protocol
  • Meets the DSM-5 diagnostic criteria for substance use disorder; in rehabilitation for ≥1 month; withdrawal symptoms are stable (confirmed by medical staff)
  • No severe cardiovascular/cerebrovascular disease, respiratory disease, musculoskeletal injury, or other contraindications to physical activity
  • Basic reading and writing ability to independently complete questionnaire assessments
  • Voluntarily signed informed consent and committed to complying with the 8-week training program

Exclusion Criteria：

  • Presence of contraindications to exercise (e.g., recent fracture, severe arrhythmia, uncontrolled hypertension)
  • Concurrent severe mental disorders (e.g., schizophrenia, acute depressive episode) or currently receiving unstable psychiatric medication
  • Currently participating in other intervention studies or clinical trials
  • Expected training compliance rate <70% (e.g., unable to complete the 8-week intervention due to transfer or disciplinary action)
  • Unable to continue participation for personal reasons (e.g., early discharge, serious disciplinary violation)

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Double

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Resistance Breathing Training Group
Use a resistance breathing trainer and follow a progressive resistance training regimen, starting with low resistance and gradually increasing the intensity based on individual tolerance.
Dispositif: Resistance Breathing Training
Warm-up (5 minutes) → Threshold resistance breathing trainer (30 minutes) → Cool-down stretches (5 minutes).During joint training, each session lasts 15 minutes.
Autres noms:
  • Three-Ball Breathing Trainer
  • Patent Number：2021212828371
Expérimental: Aerobic Exercise Group
This session features moderate-intensity aerobic exercise, with intensity maintained at 60-70% of maximum heart rate, and includes a warm-up, main workout, and cool-down.
Comportemental: Aerobic Exercise
Warm-up (5 minutes) → Main exercise (30 minutes, at 65%-85% of maximum heart rate or a Borg RPE score of 12-14) → Cool-down and stretching (5 minutes).During joint training sessions, each training session lasts 15 minutes.
Autres noms:
  • Audio
Expérimental: Joint Training Group
After the warm-up, start with 15 minutes of resistance breathing exercises, followed by 15 minutes of aerobic exercise, and then five minutes of stretching.
Dispositif: Resistance Breathing Training
Warm-up (5 minutes) → Threshold resistance breathing trainer (30 minutes) → Cool-down stretches (5 minutes).During joint training, each session lasts 15 minutes.
Autres noms:
  • Three-Ball Breathing Trainer
  • Patent Number：2021212828371
Comportemental: Aerobic Exercise
Warm-up (5 minutes) → Main exercise (30 minutes, at 65%-85% of maximum heart rate or a Borg RPE score of 12-14) → Cool-down and stretching (5 minutes).During joint training sessions, each training session lasts 15 minutes.
Autres noms:
  • Audio

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Quality of Life Scale for Drug Addicts
Délai: Baseline (Week 0), after the intervention (Week 9)
Minimum score: 41, Maximum score: 205.Higher scores indicate worse quality of life and more severe impairment in physical, psychological, social, and withdrawal-related symptoms.
Baseline (Week 0), after the intervention (Week 9)
6-Minute Walk Test
Délai: Baseline (Week 0), after the intervention (Week 9)
The maximum distance a subject can cover in 6 minutes while walking at maximum speed along a 30-meter flat corridor. This test is used to assess cardiopulmonary function and exercise endurance during submaximal exercise.
Baseline (Week 0), after the intervention (Week 9)

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
BMI
Délai: Baseline (Week 0), after the intervention (Week 9)
Weight (kg) and height (m) will be combined and reported as BMI, expressed in kg/m²
Baseline (Week 0), after the intervention (Week 9)
Body Composition
Délai: Baseline (Week 0), after the intervention (Week 9)
Data was measured and analyzed using bioelectrical impedance analysis (BIA) with a body composition analyzer (MC-780MA, TANITA), including: body fat mass, skeletal muscle mass, body water, visceral fat, and basal metabolic rate.
Baseline (Week 0), after the intervention (Week 9)
Symptom Checklist-90
Délai: Baseline (Week 0), after the intervention (Week 9)
Symptom Checklist-90 (SCL-90); range 90-450; higher scores = worse mental health. Dimensions: somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, psychoticism, sleep and eating.
Baseline (Week 0), after the intervention (Week 9)
Vital Capacity
Délai: Baseline (Week 0), after the intervention (Week 9)
A spirometer is used to measure the maximum volume of air a subject can exhale after taking a deep breath. This measurement is used to assess lung ventilation function. The unit of measurement is milliliters (mL).
Baseline (Week 0), after the intervention (Week 9)

Autres mesures de résultats

Mesure des résultats
Description de la mesure
Délai
Blood pressure
Délai: Baseline (Week 0), after the intervention (Week 9)
Unit: mmHg; Abnormal value = Poor cardiovascular health
Baseline (Week 0), after the intervention (Week 9)
Oxygen Saturation
Délai: Baseline (Week 0), after the intervention (Week 9)
The percentage of peripheral blood oxygen saturation measured using a pulse oximeter at rest. Used to assess the body's oxygenation status and respiratory efficiency. Unit: %
Baseline (Week 0), after the intervention (Week 9)
Resting heart rate
Délai: Baseline (Week 0), after the intervention (Week 9)
The unit is "beats per minute (bpm)"; measurements are taken using standard heart rate monitoring equipment while the subject is at rest, and are used to assess baseline cardiovascular function.
Baseline (Week 0), after the intervention (Week 9)
Peak expiratory flow
Délai: Baseline (Week 0), after the intervention (Week 9)
The peak expiratory flow rate, measured in liters per minute using a spirometer during a forced exhalation, directly reflects airway patency and respiratory muscle strength; a higher value indicates better respiratory function.
Baseline (Week 0), after the intervention (Week 9)
Visual Analogue Scale for Drug Craving
Délai: Baseline (Week 0), after the intervention (Week 9)
Visual Analogue Scale for Drug Craving (VAS)Minimum score: 0, Maximum score: 10.Higher scores indicate more severe drug craving.
Baseline (Week 0), after the intervention (Week 9)
Grip strength
Délai: Baseline (Week 0), after the intervention (Week 9)
Grip strength (kg): The maximum grip force measured using a handheld dynamometer, used to assess upper body strength.
Baseline (Week 0), after the intervention (Week 9)
Back Scratch Test
Délai: Baseline (Week 0), after the intervention (Week 9)
Shoulder joint range of motion and upper limb flexibility are assessed by measuring the distance between the middle fingers when the hands are placed as close together as possible behind the back. The unit is centimeters (cm); a negative value indicates that the fingers overlap, while a positive value indicates that they do not overlap.
Baseline (Week 0), after the intervention (Week 9)
Number of repetitions in the 30-second chair stand test
Délai: Baseline (Week 0), after the intervention (Week 9)
The maximum number of times a person can stand up completely from a standard chair and sit back down within 30 seconds, used to assess lower limb function
Baseline (Week 0), after the intervention (Week 9)

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Southwest Medical University

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 avril 2026

Achèvement primaire (Estimé)

10 juin 2026

Achèvement de l'étude (Estimé)

30 juin 2026

Dates d'inscription aux études

Première soumission

28 avril 2026

Première soumission répondant aux critères de contrôle qualité

11 mai 2026

Première publication (Réel)

18 mai 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

18 mai 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

11 mai 2026

Dernière vérification

1 avril 2026

Plus d'information

Termes liés à cette étude

Termes MeSH pertinents supplémentaires

Autres numéros d'identification d'étude

  • SWMUIRBTX-202603-0015

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner